Efficacy/Safety Study of R-CHOP vs Bortezomib-R-CAP for Young Patients With Diffuse Large B-cell Lymphoma With Poor IPI.
Clinical trial NCT01848132 · COMPLETED
Trial details
- NCT number
- NCT01848132
- Sponsor
- Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-03
- Primary completion
- 2018-01-01
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.